scholarly journals Patient Age and Dentists' Decisions About Occlusal Caries Treatment Thresholds

2014 ◽  
Vol 39 (5) ◽  
pp. 473-480 ◽  
Author(s):  
N Kakudate ◽  
F Sumida ◽  
Y Matsumoto ◽  
Y Yokoyama ◽  
GH Gilbert ◽  
...  

SUMMARYObjectivesThis study was performed to 1) quantify dentists' treatment thresholds for occlusal primary caries; 2) determine if the patient's age affects dentists' decisions to surgically treat these carious lesions; and 3) test the hypothesis that patients', dentists', and practices' characteristics are significantly associated with surgical enamel intervention.MethodsThe study used a cross-sectional design consisting of a questionnaire survey in Japan. This study queried dentists working in outpatient dental practices who were affiliated with the Dental Practice-Based Research Network Japan (JDPBRN), which aims to allow dentists to investigate research questions and share experiences and expertise (n=282). Participants were asked whether they would surgically intervene in a series of cases depicting occlusal caries. Each case included a photograph of an occlusal surface displaying typical characteristics of caries penetration and written descriptions of adult and pediatric patients at high caries risk.ResultsIn a case of a carious lesion within inner enamel, the proportion of dentists who indicated surgical intervention was significantly higher in adult patients (48%) when compared with pediatric patients (34%; p<0.01). Logistic regression analysis showed that using a dental explorer for the diagnosis of primary occlusal caries, type of practice, practice busyness, and percentage of patients who self-pay were significantly associated with dentists' decisions to intervene surgically into the inner enamel carious lesion.ConclusionsThese findings demonstrate that more than one-third of participants chose to intervene surgically into inner enamel carious lesions, and patients' age affects dentists' decisions about when to intervene surgically (clinicaltrials.gov registration number NCT01680848).

2014 ◽  
Vol 48 (3) ◽  
pp. 200-207 ◽  
Author(s):  
S.K. Makhija ◽  
G.H. Gilbert ◽  
E. Funkhouser ◽  
J.D. Bader ◽  
V.V. Gordan ◽  
...  

2020 ◽  
Vol 26 (5) ◽  
pp. 417
Author(s):  
Brett Vaughan ◽  
Michael Fleischmann ◽  
Kylie Fitzgerald ◽  
Sandra Grace ◽  
Paul Orrock ◽  
...  

The study aimed to compare the characteristics of Australian osteopaths who definitely agree that prescribing scheduled medicines is part of their future scope of practice with those who do not. A secondary analysis of a cross-sectional survey of osteopaths from an Australian practice-based research network was undertaken. Demographic, practice and treatment characteristics were identified using inferential statistics and backward linear regression modelling. Over one-quarter (n=257, 25.9%) of the total participants (n=992) indicated that they ‘definitely’ agree that osteopaths should seek prescription rights. Adjusted odds ratios (OR) suggested these osteopaths were more likely to engage in medication discussions with patients (OR 1.88), frequently manage migraines (OR 1.68) and seek increased practice rights for referrals to medical specialists (OR 2.61) and diagnostic imaging (OR 2.79). Prescribing as part of the future scope of practice for Australian osteopaths is associated with patient management (medication discussions) and practice characteristics (increased referral rights for specialists and diagnostic imaging) that warrant additional investigation. Understanding of the practice, clinical and patient management characteristics of Australian osteopaths who see prescribing as part of the future scope of practice informs the case for regulatory and health policy changes for prescribing scheduled medicines.


2010 ◽  
Vol 141 (2) ◽  
pp. 171-184 ◽  
Author(s):  
Valeria V. Gordan ◽  
James D. Bader ◽  
Cynthia W. Garvan ◽  
Joshua S. Richman ◽  
Vibeke Qvist ◽  
...  

2020 ◽  
Vol 29 (5) ◽  
Author(s):  
Micheline Maire ◽  
Stefanie Linder ◽  
Charles Dvořák ◽  
Christoph Merlo ◽  
Stefan Essig ◽  
...  

Materials ◽  
2021 ◽  
Vol 14 (21) ◽  
pp. 6272
Author(s):  
Amel Slimani ◽  
Salvatore Sauro ◽  
Patricia Gatón Hernández ◽  
Sevil Gurgan ◽  
Lezize Sebnem Turkun ◽  
...  

The contemporary approach for operative caries management emphasizes personalized interventions for each patient, dependent upon the individual’s caries susceptibility/risk, the stage of the carious lesion and its activity. The clinician’s challenge is to optimize the extent of cavity preparation and the choice of dental restorative biomaterials, appreciating the benefits offered by ion-releasing restorative materials. There is a growing application of bioactive/bio-interactive materials in minimally invasive operative dentistry, as they may help with tissue recovery by ion release. In case of moderate or extensive occlusal cavitation, the clinical criteria include the individual caries susceptibility and carious lesion activity. In high caries risk cases, ion-releasing biomaterials (IRB) can be used, as well as for active carious lesions. In proximal lesions, the clinical criteria include the individual caries susceptibility, the lesion activity and presence of cavities with little or no enamel at the gingival margin. This article aims to discuss the restorative ion-releasing options, according to different clinical situations, and the caries susceptibility to manage cavitated carious lesions in permanent adult teeth.


2016 ◽  
Vol 156 (3) ◽  
pp. 518-524 ◽  
Author(s):  
Stephanie Misono ◽  
Schelomo Marmor ◽  
Nelson Roy ◽  
Ted Mau ◽  
Seth M. Cohen

Objective To identify factors associated with the likelihood of attending voice therapy among patients referred for it in the CHEER (Creating Healthcare Excellence through Education and Research) practice-based research network infrastructure. Study Design Prospectively enrolled cross-sectional study. Setting CHEER network of community and academic sites. Methods Data were collected on patient-reported demographics, voice-related diagnoses, voice-related handicap (Voice Handicap Index–10), likelihood of attending voice therapy (VT), and opinions on factors influencing likelihood of attending VT. The relationships between patient characteristics/opinions and likelihood of attending VT were investigated. Results A total of 170 patients with various voice-related diagnoses reported receiving a recommendation for VT. Of those, 85% indicated that they were likely to attend it, regardless of voice-related handicap severity. The most common factors influencing likelihood of VT attendance were insurance/copay, relief that it was not cancer, and travel. Those who were not likely to attend VT identified, as important factors, unclear potential improvement, not understanding the purpose of therapy, and concern that it would be too hard. In multivariate analysis, factors associated with greater likelihood of attending VT included shorter travel distance, age (40-59 years), and being seen in an academic practice. Conclusions Most patients reported plans to attend VT as recommended. Patients who intended to attend VT reported different considerations in their decision making from those who did not plan to attend. These findings may inform patient counseling and efforts to increase access to voice care.


BMJ Open ◽  
2019 ◽  
Vol 9 (2) ◽  
pp. e023731 ◽  
Author(s):  
Dee Mangin ◽  
Jenna Parascandalo ◽  
Olga Khudoyarova ◽  
Gina Agarwal ◽  
Verdah Bismah ◽  
...  

ObjectiveThere is increasing awareness of the burden of medical care experienced by those with multimorbidity. There is also increasing interest and activity in engaging patients with chronic disease in technology-based health-related activities (‘eHealth’) in family practice. Little is known about patients’ access to, and interest in eHealth, in particular those with a higher burden of care associated with multimorbidity. We examined access and attitudes towards eHealth among patients attending family medicine clinics with a focus on older adults and those with polypharmacy as a marker for multimorbidity.DesignCross-sectional survey of consecutive adult patients attending consultations with family physicians in the McMaster University Sentinel and Information Collaboration practice-based research network. We used univariate and multivariate analyses for quantitative data, and thematic analysis for free text responses.SettingPrimary care clinics.Participants693 patients participated (response rate 70%). Inclusion criteria: Attending primary care clinic. Exclusions: Too ill to complete survey, cannot speak English.ResultsThe majority of participants reported access to the internet at home, although this decreased with age. Participants 70 years and older were less comfortable using the internet compared with participants under 70. Univariate analyses showed age, multimorbidity, home internet access, comfort using the internet, privacy concerns and self-rated health all predicted significantly less interest in eHealth. In the multivariate analysis, home internet access and multimorbidity were significant predictors of disinterest in eHealth. Privacy and loss of relational connection were themes in the qualitative analysis.ConclusionThere is a significant negative association between multimorbidity and interest in eHealth. This is independent of age, computer use and comfort with using the internet. These findings have important implications, particularly the potential to further increase health inequity.


2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 1351.1-1351
Author(s):  
F. Veenstra ◽  
J. Vriezekolk ◽  
H. J. Schers ◽  
N. Van Herwaarden ◽  
B. Van den Bemt ◽  
...  

Background:Uric acid lowering therapy (ULT) can be effective in gout if taken correctly (1), but non-adherence is a known problem (2). Although patients’ adherence barriers regarding ULT, such as lack of knowledge on disease and therapy, and beliefs, have been widely studied (3), less is known physicians’ beliefs.Objectives:To investigate the physicians’ beliefs on ULT treatment in both primary and secondary care in the Netherlands.Methods:Cross-sectional study among all rheumatologists of the Sint Maartenskliniek and to all General Practitioners (GPs) of 17 practices, participating in the practice-based research network Family Medicine Network Nijmegen, Netherlands. All participants filled out the beliefs about medication questionnaire (BMQ), adjusted for physicians; in addition data were collected on physician characteristics including working experience in total and gout consultations. The BMQ consists of two parts, a specific part with 10 questions about beliefs on necessity (N=5) and concerns (N=5) regarding ULT and a general part with 8 questions about beliefs on harms (N=4) and overuse (N=4) regarding medication in general. Each question is scored on a Likert-scale from 1-5, a higher score corresponds to higher beliefs on that category. Sum scores for all four categories were calculated. With the total scores on the specific BMQ including necessity and concerns beliefs, physicians were classified in four different categories (Table 1)(4).Results:In total 112 physicians received the questionnaire, 28 of 37 rheumatologists (76%) and 45 of 75 GPs (60%) responded. Rheumatologists had less years of experience than GPs (median 8.5 years (IQR 3 – 14) versus (vs) 13 years (IQR 8-20)) and less hours of patient contact per week (15 hours (IQR 8.5 – 20) vs 24 hours (IQR 20 – 30)). Rheumatologists reported more consultations for gout per week than GPs: median 4 (IQR 1 – 6.6) vs 1 (IQR 0.2– 1).Rheumatologists scored higher on the BMQ necessity scale, 17.5 (95% CI 16.6 – 18.5) compared to GPs 16.1 (95% CI 15.1 – 17.1). GPs scored higher on BMQ concern scale, 12.1 (95% CI 11.4 – 12.7) compared to rheumatologists, 10.4 (95% CI 9.7 – 11.2). On medication in general, GPs scored higher on both overuse and harms scales compared to rheumatologists, 11.3 (95% CI 10.7 – 12) versus 9.9 (95% CI 9 – 10.7)and 8.3 (95% CI 7.9 – 8.7) vs 7.1 (95% CI 6.5 – 7.7), respectively. Table 1 shows classification according to the BMQ specific for both groups.Table 1.Classification based on the adapted BMQRheumatologists (N=28)GPs (N=45)Acceptant (%)19 (67.9)16 (35.6)Ambivalent (%)08 (17.8)Sceptic (%)1 (3.6)5 (11.1)Indifferent (%)8 (28.6)16 (35.6)Conclusion:For the majority of rheumatologist the necessity beliefs outweighs concern beliefs towards the use of ULT outweighs concern beliefs. GPs show a more heterogenic profile, including acceptant, indifferent and ambivalent beliefs towards ULT use. GPs also show higher harm and overuse concerns regarding medication in general. Next step is to investigate possible associations with actual ULT use and disease outcome.References:[1]Doherty M, et al. Lancet (London, England). 2018;392(10156):1403-12.[2]Reach G. Joint, bone, spine: revue du rhumatisme. 2011;78(5):456-9.[3]Harrold LR et al. Chronic illness. 2010;6(4):263-71.[4]Toelichting BMQ. [updated 2011-12-10; cited 2021-01-28] Available trough: https://meetinstrumentenzorg.nl/instrumenten/beliefs-about-medicine-questionnaire-bmq-bmq-specific-bmq-general/Acknowledgements:This study is sponsored by GrünenthalDisclosure of Interests:Frouwke Veenstra: None declared., Johanna Vriezekolk: None declared., Henk J Schers: None declared., Noortje van Herwaarden: None declared., Bart van den Bemt Speakers bureau: Pfizer, AbbVie, UCB, Biogen and Sandoz, Consultant of: Delivered consultancy work for UCB, Novartis and Pfizer, Grant/research support from: UCB, Pfizer and Abbvie, Marcel Flendrie Consultant of: M. Flendrie has received consultancy fees from Menarini and Grunenthal., Grant/research support from: M. Flendrie has received grants from Menarini and Grunenthal.


2019 ◽  
Vol 84 ◽  
pp. 76-80 ◽  
Author(s):  
Naoki Kakudate ◽  
Yoko Yokoyama ◽  
Futoshi Sumida ◽  
Yuki Matsumoto ◽  
Valeria V. Gordan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document